The Valley Desk

NCT02363283 · Interventional trial

Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma

Overall registry status Completed

Phase 2

Conditions Recurrent Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov